Pathomorphological changes in mouse liver and kidney during prolonged valproate administration.
Mice given sodium valproate 0.71% weight/volume in drinking water for 7, 14 and 21 days were assessed for pathomorphological changes in liver and kidney tissues at certain time points. This treatment caused a marked alteration in liver and kidney cell morphology, which was proportional to the period of treatment. This treatment induced fatty degeneration of hepatocytes, increased the number of Kupffer cells and caused them to swell. These changes were irregular after days 7 and 14 of treatment but with time increased in intensity, producing inflammation of the portal tracts, albuminous degeneration and necrosis of septa. Precirrhotic conditions, cirrhosis, acidophilic degeneration of hepatocytes and glassy eosinophilic homogenous cytoplasm were a constant feature after 21 days' treatment. In some cases the portal area was invaded by small, round inflammatory cells. Hepatocytes in this group were swollen, with large nuclei and increased amounts of condensed chromatin. The kidney sections of the same animals revealed severe morphological changes, indicated by significant epithelial necrosis and sloughing of tubules, as well as cast formation and mild lymphocytic infiltrate after 21 days' treatment. The results suggest that the histopathologic changes induced by sodium valproate are dependent upon the duration of exposure of these organs to the drug. Prolonged use of this drug should be carefully assessed.
Raza
M
M
Department of Pharmacology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia. mrsheikh@ksu.edu.sa
al-Shabanah
O A
OA
al-Bekairi
A M
AM
Qureshi
S
S
D000818:Animals; D056486:Chemical and Drug Induced Liver Injury; D004334:Drug Administration Schedule; D004827:Epilepsy / Q000188:drug therapy*; D007668:Kidney / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D008099:Liver / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D008107:Liver Diseases / Q000473:pathology / Q000503:physiopathology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D014635:Valproic Acid / Q000633:toxicity*
D014635:Valproic Acid